Takuya Tsunoda

8PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingMolecular targetsImmunogenetics (incl. genetic immunology)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 27, 2026
Efficacy and safety of necitumumab and pembrolizumab combination therapy in advanced non-small-cell lung cancer with ≥50% PD-L1 expression: A nonrandomized phase II trial.

|Dec 30, 2025
Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study.

Risako Suzuki, Ryotaro Ohkuma, Makoto Watanabe

|Oct 24, 2025
Increased alanine aminotransferase level as a predictive marker of hand-foot syndrome in patients receiving capecitabine: A retrospective cohort study.

Mei Yamaguchi, Hideki Sugita, Eisuke Inoue

|Jul 29, 2025
Plasma WFDC2 (HE4) as a Predictive Biomarker for Clinical Outcomes in Cancer Patients Receiving Anti-PD-1 Therapy: A Pilot Study.

Makoto Watanabe, Katsuaki Ieguchi, Takashi Shimizu

|Jun 06, 2025
Combination therapy with levofloxacin and the probiotic Clostridium butyricum MIYAIRI 588 enhances immune checkpoint inhibitor efficacy.

Kohei Tajima, Masahiro Hosonuma, Eiji Funayama

|Feb 11, 2023
Superiority of [11C]methionine over [18F]deoxyglucose for PET Imaging of Multiple Cancer Types Due to the Methionine Addiction of Cancer.

Yutaro Kubota, Toshihiko Sato, Chihiro Hozumi

Pageof 2

Frequent Collaborators

4 joint publications

Satoshi Wada

3 joint publications

Yutaro Kubota

2 joint publications

Kazuyuki Hamada

2 joint publications

Katsuaki Ieguchi